Merck

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Merck 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About MRK

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. 

CEO
Robert M. Davis
CEORobert M. Davis
Employees
75,000
Employees75,000
Headquarters
Rahway, New Jersey
HeadquartersRahway, New Jersey
Founded
1891
Founded1891
Employees
75,000
Employees75,000

MRK Key Statistics

Market cap
269.56B
Market cap269.56B
Price-Earnings ratio
15.24
Price-Earnings ratio15.24
Dividend yield
2.99%
Dividend yield2.99%
Average volume
9.57M
Average volume9.57M
High today
$116.40
High today$116.40
Low today
$107.40
Low today$107.40
Open price
$109.98
Open price$109.98
Volume
16.61M
Volume16.61M
52 Week high
$125.14
52 Week high$125.14
52 Week low
$73.31
52 Week low$73.31

Stock Snapshot

As of today, Merck(MRK) shares are valued at $109.42. The company's market cap stands at 269.56B, with a P/E ratio of 15.24 and a dividend yield of 3.0%.

As of 2026-04-30, Merck(MRK) stock has fluctuated between $107.40 and $116.40. The current price stands at $109.42, placing the stock +1.9% above today's low and -6.0% off the high.

The Merck(MRK)'s current trading volume is 16.61M, compared to an average daily volume of 9.57M.

During the past year, Merck(MRK) stock moved between $73.31 at its lowest and $125.14 at its peak.

During the past year, Merck(MRK) stock moved between $73.31 at its lowest and $125.14 at its peak.

MRK News

TipRanks 52m
Merck comments on TERN-701 positive for Enliven’s ELVN-001, says Mizuho

Mizuho reiterated an Outperform rating and $45 price target on Enliven (ELVN) after Merck (MRK) noted during its Q1 call that it believes Terns’ (TERN) TERN-701...

Nasdaq 2h
Merck Q1 2026 Earnings Call Transcript

AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX ADP SBUX MRNA AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX AD...

Merck Q1 2026 Earnings Call Transcript
Benzinga 3h
Merck Swings To Quarterly Loss On Cidara Deal

Merck Q1 Earnings Key Takeaways Merck reported a first-quarter adjusted loss of $1.28, better than the analyst expectation of a loss of $1.51, down from earning...

Merck Swings To Quarterly Loss On Cidara Deal

Analyst ratings

69%

of 29 ratings
Buy
69%
Hold
31%
Sell
0%

More MRK News

CNBC 10h
Merck beats quarterly estimates on strength of Keytruda and new products, narrows outlook

Key Points Merck reported first-quarter results that topped estimates on strong demand for its cancer immunotherapy Keytruda and some newer products. The pharm...

Merck beats quarterly estimates on strength of Keytruda and new products, narrows outlook
Simply Wall St 2d
Merck Broadens Growth Story With Heart Campaign And New Drug Approvals

Merck (NYSE:MRK) has launched its Playing with Heart cardiovascular awareness campaign in partnership with several professional baseball teams. The company rec...

Merck Broadens Growth Story With Heart Campaign And New Drug Approvals

People also own

Based on the portfolios of people who own MRK. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.